Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. It offers DIRECTINJECT-LCTM, a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. It also provides intellectual property and contract research services. It serves pharmaceutical, critical minerals, and chemical industries. Telescope Innovations Corp. has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide. Telescope Innovations Corp. has a development and collaboration agreement with AGI Group's Synthesis, Digitization, and Automation program to develop the next generation of automation- and AI-ready chemical reactor technology. Telescope Innovations Corp. is based in Vancouver, Canada.
Frequently asked questions
What sector does Telescope Innovations Corp. (TELI) operate in?
Telescope Innovations Corp. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Telescope Innovations Corp. (TELI) current stock price?
As of the latest data, Telescope Innovations Corp. stock price is CA$0.43, with a previous close of CA$0.42. Telescope Innovations Corp. gained CA$0.01 in the last trading session, representing a 1.19% increase.
What is Telescope Innovations Corp. (TELI) current market capitalization?
Telescope Innovations Corp. market cap is approximately 34.34 million.
What is Telescope Innovations Corp. (TELI) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.06.
Does Telescope Innovations Corp. (TELI) pay dividends?
No. Telescope Innovations Corp. does not pay a dividend.
What is Telescope Innovations Corp. (TELI) beta (volatility) score?
Telescope Innovations Corp. has a beta of 1.333, suggesting it is more volatile than the market.
